Burning Rock Biotech (BNR) Cash from Operations (2019 - 2025)

Burning Rock Biotech's Cash from Operations history runs 7 years deep, the most recent figure standing at 3293000.0 for Q4 2025.

• In Q4 2025, Cash from Operations rose 26.12% year-over-year to 3293000.0; the TTM figure through Dec 2025 stood at 7121000.0 (up 70.86% YoY), while the FY2025 annual figure was 4068000.0, up 67.82% from the prior year.
• Cash from Operations was 3293000.0 for Q4 2025 at Burning Rock Biotech, up from 2303000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 3293000.0 in Q4 2025 to a low of 22772000.0 in Q1 2022.
• Historically, Cash from Operations has averaged 10469994.01 across 5 years, with a median of 10221440.14 in 2022.
• The sharpest annual moves came in 2021 and 2024: Cash from Operations plunged 1632.5% in 2021, then soared 215.74% in 2024.
• A 5-year view of Cash from Operations shows it stood at 17628000.0 in 2021, then soared by 46.0% to 9519880.29 in 2022, then soared by 76.3% to 2256000.0 in 2023, then jumped by 215.74% to 2611000.0 in 2024, then gained by 26.12% to 3293000.0 in 2025.
• The last three Cash from Operations figures came in at 3293000.0 (Q4 2025), 2303000.0 (Q3 2025), and 9475000.0 (Q2 2025), per Business Quant data.